The drug – a new dry powder intranasal formulation of the well-established migraine therapy dihydroergotamine mesylate (DHE ... the FDA for its Trudhesa nasal spray product in 2021, and ...

DHE is an established medication used to treat migraines and cluster headaches. It is sold under brand names such as Migranal ...